Cite
HARVARD Citation
Ferrero, S. et al. (n.d.). FIRST APPLICATION OF MINIMAL RESIDUAL DISEASE ANALYSIS IN SPLENIC MARGINAL ZONE LYMPHOMA TRIALS: PRELIMINARY RESULTS FROM BRISMA/IELSG36 PHASE II STUDY. Hematological oncology. pp. 224-225. [Online].